New Drugs
| Brand/Generic | Company | Description |
|---|---|---|
|
ABECMA idecabtagene vicleucel Click here for more information |
BMS | An immunotherapy agent for treatment of relapsed or refractory multiple myeloma. |
|
Aduhelm aducanumab-avwa Click here for more information |
Biogen | An amyloid beta-directed antibody for Alzheimer’s disease. |
|
Amondys 45 casimersen Click here for more information |
Sarepta Therapeutics | An antisense oligonucleotide for treatment of Duchenne muscular dystrophy. |
|
Azstarys Serdexmethylphenidate/dexmethylphenidate Click here for more information |
Corium | A CNS stimulant for ADHD. |
|
Brexafemme ibrexafungerp Click here for more information |
Scynexis | A triterpenoid antifungal for vulvovaginal candidiasis. |
|
Breyanzi lisocabtagene maraleucel Click here for more information |
BMS | An immunotherapy agent for treatment of relapsed or refractory large B-cell lymphoma. |
|
Bylvay odevixibat Click here for more information |
Albireo Pharma | An ileal bile acid transporter inhibitor for itching due to familial intrahepatic cholestasis. |
|
Byooviz ranibizumab-nuna Click here for more information |
Biogen | New biosimilar to Lucentis. |
|
Cabenuva cabotegravir and rilpivirine Click here for more information |
ViiV Healthcare | A co-packaged injectable integrase strand transfer inhibitor and non-nucleoside reverse transcriptase inhibitor for HIV-1 infection. |
|
Comirnaty COVID-19 vaccine, mRNA Click here for more information |
Pfizer | Vaccine to prevent COVID-19 in patients 16 years of age and older. |
|
Cosela trilaciclib Click here for more information |
G1 Therapeutics | A kinase inhibitor to decrease the incidence of chemotherapy-induced myelosuppression. |
|
Empaveli pegcetacoplan Click here for more information |
Apellis Pharm. | A complement inhibitor for paroxysmal nocturnal hemoglobinuria. |
|
Evkeeza evinacumab-dgnb Click here for more information |
Regeneron | A monoclonal antibody for homozygous familial hypercholesterolemia. |
|
Exkivity mobocertinib Click here for more information |
Takeda Pharm. | A kinase inhibitor for advanced or metastatic non-small cell lung cancer. |
|
Fotivda tivozanib |
Aveo Pharm. | A kinase inhibitor for renal cell carcinoma. |
|
Jemperli dostarlimab-gxly Click here for more information |
GSK | A monoclonal antibody for endometrial cancer. |
|
Kerendia finerenone Click here for more information |
Bayer HealthCare | A non-steroidal mineralocorticoid receptor antagonist for patients with chronic kidney disease associated with type 2 diabetes. |
|
Korsuva difelikefalin Click here for more information |
Vifor | A kappa opioid receptor agonist for hemodialysis patients with pruritus associated with chronic kidney disease. |
|
Livmarli maralixibat Click here for more information |
Mirum Pharm. | An ileal bile acid transporter inhibitor for cholestatic pruritus in patients with Alagille syndrome. |
|
Lumakras sotorasib Click here for more information |
Amgen | A RAS GTPase inhibitor for advanced or metastatic non-small cell lung cancer. |
|
Lupkynis voclosporin Click here for more information |
Aurinia Pharm. | A calcineurin-inhibitor immunosuppressant for active lupus nephritis. |
|
Lybalvi olanzapine/samidorphan Click here for more information |
Alkermes | Combination atypical antipsychotic and opioid antagonist for schizophrenia and bipolar I disorder. |
|
Nextstellis drospirenone / estetrol Click here for more information |
Mayne Pharma | A new combination progestin (drospirenone) and estrogen (estetrol) oral contraceptive. |
|
Nexviazyme avalglucosidase alfa-ngpt Click here for more information |
Genzyme | A hydrolytic lysosomal glycogen-specific enzyme for late-onset Pompe disease. |
|
Nulibry fosdenopterin |
Origin Biosciences | A cyclic pyranopterin monophosphate to reduce risk of mortality in patients with molybdenum cofactor deficiency Type A. |
|
Pepaxto melphalan flufenamide Click here for more information |
Oncopeptides | An alkylating drug for relapsed or refractory multiple myeloma. |
|
Ponvory ponesimod Click here for more information |
Janssen | An oral sphingosine 1-phosphate receptor modulator for relapsing forms of multiple sclerosis. |
|
Prevnar 20 pneumococcal 20-valent conjugate vaccine Click here for more information |
Pfizer | New vaccine for prevention of pneumonia caused by 20 serotypes of Streptococcus pneumoniae. |
|
Pylarify piflufolastat F 18 Click here for more information |
Progenics Pharm. | A radioactive diagnostic agent for PET scans of prostate cancer lesions. |
|
Qelbree viloxazine Click here for more information |
Supernus Pharm. | A selective norepinephrine reuptake inhibitor for ADHD. |
|
Qulipta atogepant Click here for more information |
AbbVie | An oral calcitonin gene-related peptide receptor antagonist for migraine prevention. |
|
Rezurock belumosudil |
Kadmon Pharm. | A kinase inhibitor for patients with chronic graft-versus-host disease. |
|
Rybrevant amivantamab-vmjw Click here for more information |
Janssen Biotech | A monoclonal antibody for advanced or metastatic non-small cell lung cancer. |
|
Rylaze asparaginase erwinia chrysanthemi-rywn Click here for more information |
Jazz Pharm. | An asparagine-specific enzyme for acute lymphoblastic leukemia and lymphoblastic lymphoma in patients with hypersensitivity to E. coli-derived asparaginase. |
|
Saphnelo anifrolumab-fnia Click here for more information |
AstraZeneca | A monoclonal antibody for moderate to severe systemic lupus erythematosus. |
|
Scemblix asciminib Click here for more information |
Novartis Pharm. | A kinase inhibitor for a certain type of leukemia. |
|
Skytrofa lonapeg-somatropin-tcgd Click here for more information |
Ascendis Pharma | A human growth hormone replacement for pediatric patients who have growth failure. |
|
Susvimo ranibizumab Click here for more information |
Genentech | A monoclonal antibody for neovascular (wet) age-related macular degeneration. |
|
Tavneos avacopan Click here for more information |
ChemoCentryx | A C5aR antagonist for severe ANCA-associated vasculitis. |
|
Tembexa brincidofovir Click here for more information |
Chimerix | An orthopoxvirus nucleotide analog DNA polymerase inhibitor for treatment of smallpox. |
|
Tepmetko tepotinib Click here for more information |
EMD Serono | A kinase inhibitor for metastatic non-small cell lung cancer. |
|
Tivdak tisotumab vedotin-tftv Click here for more information |
Seagen | A monoclonal antibody for recurrent or metastatic cervical cancer. |
|
Truseltiq infigratinib Click here for more information |
QED Therapeutics | A kinase inhibitor for advanced or metastatic cholangiocarcinoma. |
|
Ukoniq umbralisib Click here for more information |
TG Therapeutics | A kinase inhibitor for marginal zone lymphoma and follicular lymphoma. |
|
Verquvo vericiguat Click here for more information |
Merck | A guanylate cyclase stimulator for patients with symptomatic chronic heart failure and ejection fraction <45%. |
|
Vocabria cabotegravir Click here for more information |
ViiV Healthcare | An HIV-1 integrase strand transfer inhibitor for short-term treatment of HIV-1 infection. |
|
Welireg belzutifan Click here for more information |
Merck | A hypoxia-inducible factor inhibitor for patients with von Hippel-Lindau disease. |
|
Zegalogue dasiglucagon Click here for more information |
Zealand Pharma | A glucagon receptor agonist for severe hypoglycemia in patients with diabetes. |
|
Zynlonta loncastuximab tesirine-lpyl Click here for more information |
ADC Therapeutics | A monoclonal antibody for relapsed or refractory large B-cell lymphoma. |
| Brand/Generic | Company | Description |
|---|---|---|
|
Dyanavel XR amphetamine Click here for more information |
Tris Pharma | New extended-release tablet formulation for ADHD. |
|
Eprontia topiramate Click here for more information |
Azurity Pharm. | New oral solution formulation for epilepsy and migraine prevention. |
|
Invega Hafyera paliperidone Click here for more information |
Janssen Pharm. | New extended-release injection for every-six-month dosing. |
|
Kimyrsa oritavancin Click here for more information |
Melinta Therapeutics | New 1.2 g single-dose vial. |
|
Kloxxado naloxone Click here for more information |
Hikma Specialty | New higher strength (8 mg) nasal spray for emergency treatment of opioid overdose. |
|
Loreev XR lorazepam |
Almatica Pharma | New extended-release capsule formulation. |
|
Myfembree relugolix/estradiol/norethindrone acetate Click here for more information |
Myovant Sciences | Combination gonadotropin-releasing hormone antagonist, estrogen, and progestin for fibroid-associated heavy menstrual bleeding in premenopausal women. |
|
Opzelura ruxolitinib Click here for more information |
Incyte Corp. | New topical cream formulation Janus kinase inhibitor for atopic dermatitis. |
|
Posimir bupivacaine Click here for more information |
Durect Corp. | New formulation local anesthetic for infiltration use. |
|
Roszet rosuvastatin / ezetimibe Click here for more information |
Althera Pharm. | A new combination statin and dietary cholesterol absorption inhibitor for hyperlipidemia. |
|
Seglentis celecoxib/tramadol Click here for more information |
Kowa Pharm. | An NSAID/opioid combination for acute pain. |
|
Soaanz torsemide Click here for more information |
Sarfez Pharm. | New strength (60 mg) tablet available. |
|
Trudhesa dihydroergotamine mesylate Click here for more information |
Impel NeuroPharma | An ergotamine derivative for acute treatment of migraine. |
|
Twyneo tretinoin / benzoyl peroxide Click here for more information |
Sol-Gel Technologies | New combination cream for treatment of acne. |
|
Tyrvaya varenicline Click here for more information |
Oyster Point Pharma | New nasal spray formulation for dry eye disease. |
|
Uptravi selexipag Click here for more information |
Janssen | A new injectable formulation prostacyclin receptor agonist for pulmonary arterial hypertension. |
|
Verkazia cyclosporine Click here for more information |
Santen | New strength (0.1%) ophthalmic emulsion for vernal keratoconjunctivitis. |
|
Vuity pilocarpine Click here for more information |
Allergan | New 1.25% ophthalmic solution for presbyopia in adults. |
|
Wegovy semaglutide Click here for more information |
Novo Nordisk | A new formulation used for weight loss. |
|
Xipere triamcinolone acetonide Click here for more information |
Clearside Biomedical | An injectable corticosteroid formulation for macular edema associated with uveitis. |
|
Zimhi naloxone Click here for more information |
Adamis Pharm. | New 5 mg single-dose, prefilled syringe to reverse opioid overdose. |
|
Zynrelef bupivacaine/meloxicam Click here for more information |
Heron Therapeutics | A combination local anesthetic/NSAID for soft tissue or periarticular instillation to produce postsurgical analgesia. |
| Brand/Generic | Company | Description |
|---|